Christoph Gauger
Directeur Général chez UB4/BB GmbH & Co. KG
Profil
Christoph Gauger is currently the Outside Director & Head-Finance at Nippon Boehringer Ingelheim Co., Ltd., the Managing Director at Boehringer Ingelheim Stiftung GmbH, and the Managing Director at UB4.
He previously held positions as the Chief Executive Officer & Administrative Director at Boehringer Ingelheim Japan Investment GK, Director at SSP Co., Ltd., Project Manager at Boehringer Ingelheim GmbH, and Controller at Boehringer Ingelheim Chemicals, Inc.
Postes actifs de Christoph Gauger
| Sociétés | Poste | Début |
|---|---|---|
Nippon Boehringer Ingelheim Co., Ltd.
 Nippon Boehringer Ingelheim Co., Ltd. Pharmaceuticals: MajorHealth Technology Established in 1961, Nippon Boehringer Ingelheim Co., Ltd. develops, manufactures, imports and markets pharmaceutical products. The company is also involved in the importation and exportation of intermediates and bulk pharmaceutical products. Nippon Boehringer Ingelheim is based in Tokyo and operates in several parts of Japan through its domestic offices. | Directeur Financier/CFO | 06/09/2011 |
Boehringer Ingelheim Stiftung GmbH
 Boehringer Ingelheim Stiftung GmbH Investment Trusts/Mutual FundsMiscellaneous Boehringer Ingelheim Stiftung GmbH is a German company that engages in promoting scientific research and development. The private company is based in Ingelheim am Rhein, Germany. The company was founded in 1992. The CEO is Christoph Gauger. | Directeur Général | - |
UB4/BB GmbH & Co. KG
 UB4/BB GmbH & Co. KG Financial ConglomeratesFinance UB4/BB GmbH & Co. KG provides financial services. The private company is based in Ingelheim am Rhein, Germany. The German company was founded in 2001. The CEO is Christoph Gauger. | Directeur Général | - |
Anciens postes connus de Christoph Gauger
| Sociétés | Poste | Fin |
|---|---|---|
Boehringer Ingelheim Japan Investment GK
 Boehringer Ingelheim Japan Investment GK Financial ConglomeratesFinance Part of C.H. Boehringer Sohn AG & Co. KG, Boehringer Ingelheim Japan Investment GK is an investment holding Japanese company. The company is based in Tokyo, Japan. | President | - |
Boehringer Ingelheim GmbH
 Boehringer Ingelheim GmbH Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim GmbH engages in the provision of central management and other services for the group companies on behalf of C.H. Boehringer Sohn AG & Co. KG. The group specializes in the development, production, and distribution of pharmaceutical products. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany. | Corporate Officer/Principal | - |
Boehringer Ingelheim Chemicals, Inc.
 Boehringer Ingelheim Chemicals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Chemicals, Inc. manufactures pharmaceutical ingredients and drug intermediates. It produces guaifenesin, methocarbamol, calcium polycarbophil, metoclopramide, doxapram, diacetone fructose, and methadone. The company was founded in 1976 and is headquartered in Petersburg, VA. | Comptroller/Controller/Auditor | - |
SSP Co., Ltd.
 SSP Co., Ltd. Pharmaceuticals: MajorHealth Technology SSP Co., Ltd. engages in the manufacture and sale of pharmaceuticals, quasi-drugs and cosmetics. The company was founded in 1765 and is headquartered in Tokyo, Japan. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
SSP Co., Ltd.
SSP Co., Ltd. Pharmaceuticals: MajorHealth Technology SSP Co., Ltd. engages in the manufacture and sale of pharmaceuticals, quasi-drugs and cosmetics. The company was founded in 1765 and is headquartered in Tokyo, Japan. | Health Technology |
Boehringer Ingelheim GmbH
Boehringer Ingelheim GmbH Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim GmbH engages in the provision of central management and other services for the group companies on behalf of C.H. Boehringer Sohn AG & Co. KG. The group specializes in the development, production, and distribution of pharmaceutical products. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany. | Health Technology |
Boehringer Ingelheim Chemicals, Inc.
Boehringer Ingelheim Chemicals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Chemicals, Inc. manufactures pharmaceutical ingredients and drug intermediates. It produces guaifenesin, methocarbamol, calcium polycarbophil, metoclopramide, doxapram, diacetone fructose, and methadone. The company was founded in 1976 and is headquartered in Petersburg, VA. | Health Technology |
Boehringer Ingelheim Japan Investment GK
Boehringer Ingelheim Japan Investment GK Financial ConglomeratesFinance Part of C.H. Boehringer Sohn AG & Co. KG, Boehringer Ingelheim Japan Investment GK is an investment holding Japanese company. The company is based in Tokyo, Japan. | Finance |
Nippon Boehringer Ingelheim Co., Ltd.
Nippon Boehringer Ingelheim Co., Ltd. Pharmaceuticals: MajorHealth Technology Established in 1961, Nippon Boehringer Ingelheim Co., Ltd. develops, manufactures, imports and markets pharmaceutical products. The company is also involved in the importation and exportation of intermediates and bulk pharmaceutical products. Nippon Boehringer Ingelheim is based in Tokyo and operates in several parts of Japan through its domestic offices. | Health Technology |
Boehringer Ingelheim Stiftung GmbH
Boehringer Ingelheim Stiftung GmbH Investment Trusts/Mutual FundsMiscellaneous Boehringer Ingelheim Stiftung GmbH is a German company that engages in promoting scientific research and development. The private company is based in Ingelheim am Rhein, Germany. The company was founded in 1992. The CEO is Christoph Gauger. | Miscellaneous |
UB4/BB GmbH & Co. KG
UB4/BB GmbH & Co. KG Financial ConglomeratesFinance UB4/BB GmbH & Co. KG provides financial services. The private company is based in Ingelheim am Rhein, Germany. The German company was founded in 2001. The CEO is Christoph Gauger. | Finance |
